DUOX1 and digestive system infectious disorder: DUOX loss-of-function mutations are known in patients with very-early-onset inflammatory bowel disease (IBD)48–50, and studies from both insects and mammals show increased susceptibility to gastrointestinal infections after the knockdown of DUOX11,26.